MetLife, Inc. (NYSE:MET) Stock Position Lowered by Swiss National Bank

Swiss National Bank lessened its holdings in MetLife, Inc. (NYSE:METFree Report) by 11.9% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 2,093,700 shares of the financial services provider’s stock after selling 283,500 shares during the period. Swiss National Bank’s holdings in MetLife were worth $131,715,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Banque Cantonale Vaudoise grew its position in MetLife by 15.9% in the third quarter. Banque Cantonale Vaudoise now owns 9,023 shares of the financial services provider’s stock valued at $568,000 after acquiring an additional 1,237 shares during the period. Penobscot Investment Management Company Inc. acquired a new stake in shares of MetLife in the 3rd quarter valued at $296,000. Banco Santander S.A. increased its position in shares of MetLife by 15.8% during the 3rd quarter. Banco Santander S.A. now owns 211,710 shares of the financial services provider’s stock worth $13,319,000 after purchasing an additional 28,913 shares in the last quarter. Fidelis Capital Partners LLC bought a new position in MetLife during the 3rd quarter valued at about $232,000. Finally, J.P. Morgan Private Wealth Advisors LLC bought a new stake in MetLife during the third quarter worth about $38,669,000. 88.14% of the stock is owned by institutional investors.

MetLife Price Performance

Shares of MET stock opened at $65.95 on Monday. The company has a quick ratio of 0.13, a current ratio of 0.16 and a debt-to-equity ratio of 0.53. MetLife, Inc. has a 12-month low of $48.95 and a 12-month high of $73.12. The firm has a fifty day moving average of $66.82 and a 200-day moving average of $63.91. The firm has a market capitalization of $48.82 billion, a price-to-earnings ratio of 36.04, a price-to-earnings-growth ratio of 0.54 and a beta of 1.04.

MetLife Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 14th. Stockholders of record on Tuesday, February 6th will be issued a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 3.15%. The ex-dividend date of this dividend is Monday, February 5th. MetLife’s dividend payout ratio (DPR) is presently 113.66%.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on MET shares. UBS Group increased their target price on MetLife from $84.00 to $87.00 and gave the stock a “buy” rating in a report on Wednesday, January 10th. Keefe, Bruyette & Woods decreased their price objective on shares of MetLife from $79.00 to $77.00 and set an “outperform” rating on the stock in a report on Thursday, December 7th. Barclays restated an “overweight” rating and issued a $71.00 price objective on shares of MetLife in a research report on Friday, November 17th. Morgan Stanley increased their price target on shares of MetLife from $79.00 to $80.00 and gave the company an “overweight” rating in a research note on Thursday, November 2nd. Finally, The Goldman Sachs Group upgraded shares of MetLife from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $70.00 to $80.00 in a research report on Monday, January 8th. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $77.62.

Check Out Our Latest Report on MET

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Further Reading

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.